Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02315729

Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis

Status
Recruiting
Phase
Study type
Observational
Enrollment
380 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
Female
Age
10 Years – 13 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to identify potential markers for curve progression in adolescent idiopathic scoliosis (AIS). Despite its prevalence and impact on child health, the etiology of AIS and molecular mechanisms underlying its development and progression remain poorly understood. Clinical criteria and features cannot adequately predict which children, diagnosed with mild disease, will undergo subsequent curve progression requiring intervention. The investigators hypothesize that alterations in specific genetic markers will be correlated with the progression of AIS curves over time. Thus, these markers could be used in the future to develop a reliable, inexpensive and relatively non-invasive cell based diagnostic test to (1) predict spinal curve progression in AIS, (2) select patients likely to benefit from early surgical intervention, and (3) potentially screen for asymptomatic children at risk of developing idiopathic scoliosis.

Conditions

Timeline

Start date
2016-11-01
Primary completion
2025-12-01
Completion
2028-12-01
First posted
2014-12-12
Last updated
2023-09-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02315729. Inclusion in this directory is not an endorsement.

Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis (NCT02315729) · Clinical Trials Directory